The COVID-19 vaccine was developed using the knowledge gained from studies of SARS and MERS coronaviruses, including the identification of two proline modifications on the S-protein that preserve the protein’s antigenically optimal prefusion conformation. Here, PROS1 is linked to COVID-19.